NEW YORK (GenomeWeb News) – Chinese life science company CapitalBio will solidify its efforts to become a major laboratory testing player in the country's clinical and consumer genetics markets by opening a new facility next year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.